Triamidetriamine bearing macrobicyclic and macrotricyclic ligands: potential applications in the development of copper-64 radiopharmaceuticals
dc.contributor.author | Tan, KV | en_AU |
dc.contributor.author | Pellegrini, PA | en_AU |
dc.contributor.author | Skelton, BW | en_AU |
dc.contributor.author | Hogan, CF | en_AU |
dc.contributor.author | Greguric, ID | en_AU |
dc.contributor.author | Barnard, PJ | en_AU |
dc.date.accessioned | 2018-09-19T04:42:28Z | en_AU |
dc.date.available | 2018-09-19T04:42:28Z | en_AU |
dc.date.issued | 2013-12-16 | en_AU |
dc.date.statistics | 2018-09-18 | en_AU |
dc.description.abstract | A versatile and straightforward synthetic approach is described for the preparation of triamide bearing analogues of sarcophagine hexaazamacrobicyclic cage ligands without the need for a templating metal ion. Reaction of 1,1,1-tris(aminoethyl)ethane (tame) with 3 equiv of 2-chloroacetyl chloride, yields the tris(α-chloroamide) synthetic intermediate 6, which when treated with either 1,1,1-tris(aminoethyl)ethane or 1,4,7-triazacyclononane furnished two novel triamidetriamine cryptand ligands (7 and 8 respectively). The Co(III) and Cu(II) complexes of cryptand 7 were prepared; however, cryptand 8 could not be metalated. The cryptands and the Co(III) complex 9 have been characterized by elemental analysis, 1H and 13C NMR spectroscopy, and X-ray crystallography. These studies confirm that the Co(III) complex 9 adopts an octahedral geometry with three facial deprotonated amido-donors and three facial amine donor groups. The Cu(II) complex 10 was characterized by elemental analysis, single crystal X-ray crystallography, cyclic voltammetry, and UV–visible absorption spectroscopy. In contrast to the Co(III) complex (9), the Cu(II) center adopts a square planar coordination geometry, with two amine and two deprotonated amido donor groups. Compound 10 exhibited a quasi-reversible, one-electron oxidation, which is assigned to the Cu2+/3+ redox couple. These cryptands represent interesting ligands for radiopharmaceutical applications, and 7 has been labeled with 64Cu to give 64Cu-10. This complex showed good stability when subjected to l-cysteine challenge whereas low levels of decomplexation were evident in the presence of l-histidine. © 2013 American Chemical Society | en_AU |
dc.identifier.citation | Tan, K. V., Pellegrini, P. A., Skelton, B. W., Hogan, C. F., Greguric, I., & Barnard, P. J. (2014). Triamidetriamine bearing macrobicyclic and macrotricyclic ligands: potential applications in the development of copper-64 radiopharmaceuticals. Inorganic Chemistry, 53(1), 468-477. doi:10.1021/ic4024508 | en_AU |
dc.identifier.govdoc | 8881 | en_AU |
dc.identifier.issn | 1520-510X | en_AU |
dc.identifier.issue | 1 | en_AU |
dc.identifier.journaltitle | Inorganic Chemistry | en_AU |
dc.identifier.pagination | 468-477 | en_AU |
dc.identifier.uri | https://doi.org/10.1021/ic4024508 | en_AU |
dc.identifier.uri | http://apo.ansto.gov.au/dspace/handle/10238/9025 | en_AU |
dc.identifier.volume | 53 | en_AU |
dc.language.iso | en | en_AU |
dc.publisher | American Chemical Society | en_AU |
dc.subject | Ligands | en_AU |
dc.subject | Copper 64 | en_AU |
dc.subject | Radiopharmaceuticals | en_AU |
dc.subject | Synthesis | en_AU |
dc.subject | Amino acids | en_AU |
dc.subject | Cysteine | en_AU |
dc.subject | Histidine | en_AU |
dc.subject | Crystallography | en_AU |
dc.title | Triamidetriamine bearing macrobicyclic and macrotricyclic ligands: potential applications in the development of copper-64 radiopharmaceuticals | en_AU |
dc.type | Journal Article | en_AU |
Files
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: